Two cases of follicular lymphoma with MYC gene abnormalities that presented with bone marrow necrosis

Bone marrow necrosis (BMN) occurs most frequently in hematological malignancies and sometimes in non-hematological disorders. Lymphoid diseases causing necrosis are regarded as high-grade disease. B-lymphoblastic leukemia/lymphoma is the most common malignant cause of BMN. Here, we present two patie...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical and Experimental Hematopathology 2022, Vol.62(4), pp.208-216
Main Authors: Miyazawa, Yuri, Takei, Hisashi, Kobayashi, Nobuhiko, Akashi, Naoki, Sairenji, Yukiko, Sugisaki, Manato, Naito, Chiaki, Ishikawa, Tetsuya, Shimizu, Hiroaki, Ishizaki, Takuma, Yokohama, Akihiko, Tsukamoto, Norifumi, Yoshida, Yuka, Matsumura, Nozomi, Takayama, Yoshiyasu, Handa, Hiroshi
Format: Article
Language:English
Subjects:
bone marrow necrosis
Case Report
follicular lymphoma
hematopoiesis
MYC abnormalities
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bone marrow necrosis (BMN) occurs most frequently in hematological malignancies and sometimes in non-hematological disorders. Lymphoid diseases causing necrosis are regarded as high-grade disease. B-lymphoblastic leukemia/lymphoma is the most common malignant cause of BMN. Here, we present two patients with follicular lymphoma (FL) and MYC gene abnormalities who developed BMN. In one case of BMN, the necrosis disappeared in response to chemotherapy, and the patient survived with complete remission. In the other case, BMN remained even after chemotherapy, and effective chemotherapy could not be administered due to suppressed hematopoiesis, which led to the lymphoma worsening and the patient’s death. Indolent lymphomas, such as FL, as in these cases, have the potential to develop BMN. It is important to detect the development of BMN and administer chemotherapy early to improve patient prognosis, since severe BMN prevents patients from receiving effective treatment.
ISSN:1346-4280
1880-9952
DOI:10.3960/jslrt.22004